Fiorella Ilariucci
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 16
- Glioma Diagnosis and Treatment 3
-
- Lymphoma Diagnosis and Treatment 34
- Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 13
- Hematology top 5%
- Oncology top 10%
- Viral-associated cancers and disorders 10
-
- Lung Cancer Treatments and Mutations 6
-
- Acute Lymphoblastic Leukemia research 5
-
- Cutaneous lymphoproliferative disorders research 3
Fiorella Ilariucci
40 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 59
- Genetics 680
- Pathology and Forensic Medicine 1.1k
- Neurology 755
- Hematology 169
- Oncology 389
Countries citing papers authored by Fiorella Ilariucci
This map shows the geographic impact of Fiorella Ilariucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiorella Ilariucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiorella Ilariucci more than expected).
Fields of papers citing papers by Fiorella Ilariucci
This network shows the impact of papers produced by Fiorella Ilariucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiorella Ilariucci. The network helps show where Fiorella Ilariucci may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fiorella Ilariucci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 16 | |
| 2 | 2016 | 19 | |
| 3 | 2015 | 22 | |
| 4 | 2015 | 4 | |
| 5 | 2014 | 5 | |
| 6 | 2013 | 2 | |
| 7 | 2011 | 63 | |
| 8 | 2011 | 94 | |
| 9 | 2010 | 5 | |
| 10 | 2009 | 6 | |
| 11 | 2009 | 44 | |
| 12 | 2008 | 6 | |
| 13 | 2008 | 26 | |
| 14 | 2004 | 38 | |
| 15 | 2004 | 378 | |
| 16 | 2004 | 103 | |
| 17 | 2002 | 6 | |
| 18 | 2001 | 50 | |
| 19 | Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL). | 1999 | 10 |
| 20 | Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi. | 1998 | 7 |
About Fiorella Ilariucci
Fiorella Ilariucci is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (16 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Viral-associated cancers and disorders (10 papers), Lung Cancer Treatments and Mutations (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Glioma Diagnosis and Treatment (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). The work is most often cited by research in Genetics (680 citations), Pathology and Forensic Medicine (1.1k citations) and Neurology (755 citations). Fiorella Ilariucci has collaborated with scholars based in Italy, Ukraine and Austria. Frequent co-authors include Caterina Stelitano, Andrés J.M. Ferreri, Luca Baldini, Achille Ambrosetti, Francesco Merli, Stefano Luminari, Maurilio Ponzoni, Giuseppe Rossi, Massimo Federico and Paolo G. Gobbi. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Cancer and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.